middle.news
Proteomics International Boosts Cash with $2.2M R&D Tax Incentive
9:12am on Wednesday 12th of November, 2025 AEDT
•
Healthcare
Read Story
Proteomics International Boosts Cash with $2.2M R&D Tax Incentive
9:12am on Wednesday 12th of November, 2025 AEDT
Key Points
Received $2.2 million R&D tax incentive for 2024-25
Spent $5.15 million on research and development
Supports commercialisation of Promarker® diagnostic tests
Pipeline includes tests for diabetic kidney disease, endometriosis, and esophageal cancer
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Proteomics International Laboratories (ASX:PIQ)
OPEN ARTICLE